A single blind comparative clinical study of the effects of chlorpromazine and risperidone on positive and negative symptoms in patients of schizophrenia

Objectives: The present study was undertaken to test the comparative efficacy of chlorpromazine and risperidone in patients of schizophrenia in a tertiary care hospital of Maharashtra. Materials and Methods: About 100 subjects of either sex between 15 and 75 years of age were randomly assigned eithe...

書目詳細資料
發表在:	Indian Journal of Psychological Medicine
Main Authors:	Amrita Prakash Singam, Abhishek Mamarde, Prakash B Behere
格式:	Article
語言:	英语
出版:	SAGE Publishing 2011-01-01
主題:	Typical antipsychotic atypical antipsychotic schizophrenia
在線閱讀:	http://www.ijpm.info/article.asp?issn=0253-7176;year=2011;volume=33;issue=2;spage=134;epage=140;aulast=Singam

相似書籍

Risk factors for pneumonia in patients with schizophrenia
由: Takahiro Haga, et al.
出版: (2018-12-01)

Association of typical and atypical antipsychotics with mortality in older adults with schizophrenia: a 5-year multicenter prospective study
由: Raphaëlle Haddad, et al.
出版: (2025-08-01)

Pharmacoeconomic analysis of using typical and atypical antipsychotics in schizophrenia
由: I. A. Vilyum, et al.
出版: (2018-08-01)

The influence of typical and atypical antipsychotics on neurocognitive functions in patients with psychotic disorders
由: Javorac Jovan M., et al.
出版: (2019-01-01)

The Effect of Aspirin on Schizophrenia; A Double Blind Placebo Controlled Study
由: Hamidreza Jamilian, Gevick Hacoupian
出版: (2017-12-01)

Atypical antipsychotics in the treatment of schizophrenia
由: Swiss Medical Weekly
出版: (2003-02-01)

Evaluation of naltrexone augmentation to the antipsychotic drugs on positive and negative symptoms of schizophrenia
由: Javad Setareh, et al.
出版: (2008-01-01)

Behavioral and Psychological Symptoms in Dementia (BPSD) and the Use of Antipsychotics
由: Valeria Calsolaro, et al.
出版: (2021-03-01)

Pharmacogenetics and Schizophrenia—Can Genomics Improve the Treatment with Second-Generation Antipsychotics?
由: Olga Płaza, et al.
出版: (2022-12-01)

Acute alithiasic pancreatitis following the use of Risperidone in a young man with schizophrenia: As a rare case report
由: Boukroute Marouane, PhD, et al.
出版: (2023-07-01)

Which antipsychotics can we use for obsessive-compulsive symptoms in schizophrenia?
由: A. Aissa, et al.
出版: (2021-04-01)

A review on the pharmacology of cariprazine and its role in the treatment of negative symptoms of schizophrenia
由: Panneer Selvan, et al.
出版: (2024-04-01)

Weight Gain, Mental Symptoms and Self-Esteem in Patients with Schizophrenia
由: Sevde Öner, et al.
出版: (2022-12-01)

Treatment of antipsychotic-induced parkinsonism in schizophrenic patients
由: E. E. Vaiman, et al.
出版: (2021-08-01)

Clozapine: A special case of an atypical antipsychotic
由: Elina Marinho
出版: (2024-04-01)

COST AND EFFECTIVENESS OF ATYPICAL-ATYPICAL ANTIPSYCHOTIC COMBINATIONS AND ATYPICAL-TYPICAL ANTIPSYCHOTIC COMBINATIONS IN PATIENTS OF PSYCHOTIC DISORDERS IN INSTALLATION OF EMERGENCY IN GRHASIA MENTAL HOSPITAL, YOGYAKARTA
由: Arya Dibyo Adisaputra, et al.
出版: (2021-11-01)

Risperidone associated paralytic ileus in schizophrenia
由: Parthasarathy Ramamourthy, et al.
出版: (2013-01-01)

Efficacy and safety of lurasidone in adolescents and young adults with schizophrenia: A pooled post hoc analysis of double-blind, placebo-controlled 6-week studies
由: Isabella Costamagna, et al.
出版: (2021-01-01)

Cytokine Level Changes in Schizophrenia Patients with and without Metabolic Syndrome Treated with Atypical Antipsychotics
由: Anastasiia S. Boiko, et al.
出版: (2021-05-01)

Short-term efficacy and safety of lurasidone versus placebo in antipsychotic-naïve versus previously treated adolescents with an acute exacerbation of schizophrenia
由: Christoph U. Correll, et al.
出版: (2022-01-01)

Early non-response as a predictor of later non-response to antipsychotics in schizophrenia: a randomized trial
由: Yujun Long, et al.
出版: (2023-07-01)

Alteration of Serum Levels of Cytokines in Schizophrenic Patients before and after Treatment with Risperidone
由: Esfandiar Azizi, et al.
出版: (2019-06-01)

The efficacy, acceptability, and safety of five atypical antipsychotics in patients with first-episode drug-naïve schizophrenia: a randomized comparative trial
由: Congjie Wang, et al.
出版: (2017-12-01)

Long-term safety and effectiveness of lurasidone in adolescents and young adults with schizophrenia: pooled post hoc analyses of two 12-month extension studies
由: Fabrizio Calisti, et al.
出版: (2024-07-01)

Adverse ocular effects of neuroleptic therapy: semiotics, pathogenesis and treatment
由: A. A. Panov, et al.
出版: (2022-01-01)

Pharmacoeconomic assessment of antipsychotic treatment in outpatients with schizophrenia
由: I. A. Vilyum, et al.
出版: (2018-05-01)

Atypical antipsychotics and sexual functions in schizophrenia: A cross-sectional study
由: Charanpreet Singh, et al.
出版: (2024-01-01)

Pathophysiology and management of risperidone-induced sialorrhea: case report
由: Tyler Torrico, et al.
出版: (2023-07-01)

Analysis of the effect of brexpiprazole on sleep architecture in patients with schizophrenia: A preliminary study
由: Yusuke Arai, et al.
出版: (2023-03-01)

Atypical Antipsychotics Induced Metabolic Syndrome
由: Aysegul Demirel, et al.
出版: (2015-03-01)

A esquizofrenia e seu tratamento farmacológico
由: Cilene Rejane Ramos Alves, et al.

Comparative effectiveness of clozapine and non-clozapine atypical antipsychotics provided by the Brazilian National Health System in adults with schizophrenia
由: Júlio César Menezes Vieira, et al.
出版: (2024-06-01)

Clinical consequences of switching from olanzapine to risperidone and vice versa in outpatients with schizophrenia: 36-month results from the worldwide schizophrenia outpatients health outcomes (W-SOHO) study
由: Hong Jihyung, et al.
出版: (2012-12-01)

Association between Changes in Total Antioxidant Levels and Clinical Symptom Improvement in Patients with Antipsychotic-Naïve First-Episode Schizophrenia after 3 Months of Risperidone Monotherapy
由: Keqiang Wang, et al.
出版: (2022-03-01)

Management of cognitive and negative symptoms in schizophrenia
由: Megan Maroney, PharmD, BCPP
出版: (2022-11-01)

Blood-Based Lipidomics Approach to Evaluate Biomarkers Associated With Response to Olanzapine, Risperidone, and Quetiapine Treatment in Schizophrenia Patients
由: Adriano Aquino, et al.
出版: (2018-05-01)

Efficacy of atypical antipsychotics in schizophrenia patients: effects of 5-HTR SNPs
由: Keying Liu, et al.
出版: (2025-02-01)

C677T Polymorphism in the MTHFR Gene Is Associated With Risperidone-Induced Weight Gain in Schizophrenia
由: Jingping Liao, et al.
出版: (2020-07-01)

Altered mitochondrial lymphocyte in overweight schizophrenia patients treated with atypical antipsychotics and its association with cognitive function
由: Yaoyao Zhang, et al.
出版: (2024-01-01)

Oxidative metabolism may be associated with negative symptoms in schizophrenia
由: Mehmet Gunes, et al.
出版: (2017-01-01)